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The type III secretion system (T3SS) is a large macro-
molecular assembly found at the surface of many
pathogenic Gram-negative bacteria. Its role is to
inject toxic ‘‘effector’’ proteins into the cells of
infected organisms. The molecular details of the as-
sembly of this large, multimembrane-spanning com-
plex remain poorly understood. Here, we report
structural, biochemical, and functional analyses of
PrgK, an inner-membrane component of the proto-
typical Salmonella typhimurium T3SS. We have ob-
tained the atomic structures of the two ring building
globular domains and show that the C-terminal
transmembrane helix is not essential for assembly
and secretion. We also demonstrate that structural
rearrangement of the two PrgK globular domains,
driven by an interconnecting linker region, may pro-
mote oligomerization into ring structures. Finally,
we used electron microscopy-guided symmetry
modeling to propose a structural model for the inti-
mately associated PrgH-PrgK ring interaction within
the assembled basal body.
INTRODUCTION
Salmonella is a Gram-negative bacterium, several strains of
which are human pathogens. S. typhimurium is a major source
of food-borne enterocolitis, whereas S. typhi is the etiological
agent for typhoid fever, a disease that remains endemic in the
developing world (Haraga et al., 2008). A common feature of all
pathogenic strains of Salmonella is the presence of Salmonella
Pathogenicity Islands (SPIs) in their genome. Specifically, two
of these (SPI-1 and SPI-2) encode for type III secretion systems
(T3SS), large macromolecular assemblies responsible for the in-
jection of toxic ‘‘effector’’ proteins into the cytosol of infectedStructure 23, 16cells (Coburn et al., 2007a; de Jong et al., 2012). T3SSs
have been identified as essential pathogenicity components in
many infectious Gram-negative bacteria, including Salmonella
spp., enteropathogenic E. coli (EPEC) and enterohemorrhagic
E. coli, Pseudomonas aeruginosa, Yersinia spp., Shigella spp.,
Chlamydia spp., and Vibrio spp. (Coburn et al., 2007b; Troisfon-
taines and Cornelis, 2005). This renders the T3SS a very attrac-
tive target for the development of new antibiotics and vaccines
(Keyser et al., 2008; Kline et al., 2012; Marshall and Finlay, 2014).
A T3SS consists of a series of conserved genes coding for the
secretion apparatus (‘‘injectisome’’) and of a set of genes coding
for the effector proteins, which vary between systems and spe-
cies (Bu¨ttner, 2012; Kosarewicz et al., 2012). Effector proteins
are channeled through the injectisome to the cytosol of target
cells (Dohlich et al., 2014; Radics et al., 2014). A number of
groups have employed an integrative approach (Alber et al.,
2008) to obtain structural models of the prototypical Salmonella
SPI-1 T3SS injectisome. Electron microscopy (EM) studies have
revealed its global organization (Marlovits et al., 2004; Schraidt
et al., 2010; Schraidt and Marlovits, 2011), and the atomic struc-
tures of several isolated domains have been reported (Bergeron
et al., 2013; Lunelli et al., 2011; Spreter et al., 2009; Wang et al.,
2007). Cross-linking in combination withmass spectrometry was
employed to obtain information on the interaction between the
various components (Sanowar et al., 2009; Schraidt et al.,
2010). Finally, computational methods have been developed to
combine these data in order to obtain an atomic model of the
T3SS injectisome architecture (Bergeron et al., 2013; Demers
et al., 2013).
However, themechanistic details for the assembly of this large
complex (3.5 MDa) remain poorly understood. Genetic,
biochemical, and EM data have demonstrated that the inner-
membrane components of the injectisome can assemble inde-
pendently, with the proteins PrgK and PrgH (Figure 1A) forming
intimately nested 24-mer ring structures around the inner-mem-
brane components SpaPQRS (Kimbrough and Miller, 2000;
Wagner et al., 2010). Biochemical data also showed that in par-
allel the secretin InvG forms a pore in the outer membrane (Fig-
ure 1A), facilitated by the action of the pilotin lipoprotein InvH1–172, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 161
Figure 1. PrgK Arrangement and Localization in the T3SS
Basal Body
(A) Schematic representation of the major ring proteins that form the Salmo-
nella SPI-1 T3SS basal body within the context of the EM map used in this
study (EMD-1875). The localization of the various domains of PrgK is shown in
green.
(B) The PrgK D1 and D2 domain boundaries are indicated, as well as positions
of the putative lipidation site at Cys 18 (indicated by a squiggly line) and the TM
helix.
(C) SDS-PAGE gel of proteins secreted by S. typhimurium strains containing
mutations of PrgK’s putative membrane-embedded domains. The flagellar
protein FliC is used as an internal loading control. SipA is secreted when PrgK
is expressed and with the deletion of the C-terminal TM helix (PrgK1–200).
Secretion is abrogated with the deletion of D2 (PrgK1–92) and when the pro-
posed lipidation site is mutated (C18A).
See also Figure S1.
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Structural and Functional Characterization of PrgK(Crago and Koronakis, 1998; Okon et al., 2008; Spreter et al.,
2009). The inner-membrane and outer-membrane components
are proposed to come together through interactions of their peri-
plasmic domains and to then recruit the cytoplasmic ATPase
complex, leading to a secretion-competent complex (Sanowar
et al., 2009; Schraidt et al., 2010).
In this study, we use structural, biochemical, and functional
methods to investigate the assembly of the prototypical Salmo-
nella SPI-1 T3SS inner-membrane component, PrgK. We report
the structures of its two globular domains, and we use compu-
tational methods to propose a model for the PrgK-PrgH interac-
tion in the assembled basal body (the major T3SS injectisome
subcomplex isolated from bacteria and composed largely of
the inner and outer membrane ring components PrgH, PrgK,
and InvG; see Figure 1A). This model suggests that each
PrgH monomer docks in between adjacent PrgK subunits. We162 Structure 23, 161–172, January 6, 2015 ª2015 Elsevier Ltd All rigalso show that a linker region of PrgK may regulate oligomeriza-
tion through multiple interactions with the flanking globular
domains. Based on these results, we propose a molecular
model for the stepwise assembly of the PrgK-PrgH inner-mem-
brane ring.
RESULTS
Elucidating the Roles of PrgK’s Membrane-Embedded
Domains
PrgK is an inner-membrane component of the Salmonella SPI-1
T3SS basal body (Kimbrough and Miller, 2000) (Figure 1A). At its
N terminus, PrgK possesses a canonical lipoprotein signal
sequence, with a conserved cysteine residue (Cys 18) forming
a predicted site of lipidation (Juncker et al., 2003). Lipidation
has been experimentally confirmed in vivo for the closely related
Shigella ortholog MxiJ (44% sequence identity) (Allaoui et al.,
1992). In addition, a C-terminal transmembrane (TM) helix is pre-
dicted in all PrgK orthologs, except the EPEC T3SS component
EscJ (Figure 1B; Figure S1A available online). Nanogold labeling
experiments have shown that theC terminus of PrgK is located in
the cytoplasm, confirming that PrgK traverses the inner mem-
brane (Schraidt et al., 2010).
To assess the role of the putative N-terminal lipidation and
C-terminal TM helix for basal body assembly, we monitored
secretion of effector proteins in a S. typhimurium strain contain-
ing a chromosomal deletion of the prgK gene and complemented
with plasmids encoding WT prgK or mutants. Surprisingly,
removal of the C-terminal 52 residues, which include the cyto-
plasmic tail and TM helix (PrgK1–200), does not alter effector
secretion (Figure 1C). This observation demonstrates that the
TM helix of PrgK is not essential for inner-membrane localization
or basal body assembly. In contrast, secretion is abrogated
when the putative N-terminal lipidation site is mutated (C18A),
suggesting a requirement for the specific anchoring of PrgK to
the inner membrane via lipidation of Cys 18.
Following from the above observations, we were able to purify
intact needle complexes from Salmonella strains lacking the TM
helix of PrgK, as observed by negative-stain EM (Figures S1B
and S1C). We note that the yield of complexes obtained with
the PrgK1–200 truncation is approximately 10-fold lower than
with the WT PrgK. This suggests that the TM helix does
contribute to the overall stability of the needle complex.
Structures of the PrgK Globular Domains
Existing homology models of the PrgK ring structure (Sanowar
et al., 2009; Schraidt and Marlovits, 2011; Worrall et al., 2011)
are based on the experimental observation of a superhelical
array of 24-mer containing successive turns found in the crystal
structure of the EPEC ortholog, EscJ (26% identity) (Yip et al.,
2005). However, we showed previously that ring models of basal
body domains based on the structures of distant homologs lead
to inaccuracies, including domain misorientation and clashes,
and interfered with model convergence in our EM-guided sym-
metry modeling procedure (Bergeron et al., 2013). Therefore, in
order to obtain amore accurate PrgK ringmodel, the experimen-
tally determined structure of the PrgKmonomer was required. To
this end, we expressed a recombinant construct of its periplas-
mic domain lacking the lipidation site (PrgK19–200). This proteinhts reserved
Figure 2. Structure of the Two PrgK Globular
Domains
(A) 15N-HSQC spectrum of PrgK D1, with the as-
signed residues indicated.
(B) Overlay of the 20 lowest energy members in the
NMR-derived structural ensemble of PrgK D1, with
only the backbone trace represented.
(C) X-ray crystallographic structure of PrgK D2,
in a ribbon representation, with corresponding
sequence numbering shown. Dashed line indicates
residues not resolved in the electron density. For (B)
and (C), secondary structure elements are labeled as
in Figure S1A, and blue to red rainbow coloring in-
dicates N- to C-terminal directionality.
See Tables 1 and 2 for statistics and also Figure S2.
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Structural and Functional Characterization of PrgKcould be purified to high yield, but underwent proteolytic degra-
dation at 20C (hours) and 4C (days), leading to two products of
approximately 14 and 9 kDa size, respectively (data not shown).
Crystal and solution structures of EPEC EscJ (Crepin et al., 2005;
Yip et al., 2005) have revealed that this homologous protein pos-
sesses two globular domains (7 and 10 kDa) joined by an
extended linker (Figures 1B and S1A). We therefore purified the
two corresponding globular domains of PrgK independently.
We could not obtain crystals for the N-terminal domain
(PrgK19–76, henceforth referred to as D1). However, this protein
yielded high-quality nuclear magnetic resonance (NMR) spectra
(Figure 2A), allowing us to solve its solution structure (Figure 2B;
Table 1). Further, we were successful in obtaining crystals of the
C-terminal domain (PrgK98–200, henceforth D2) and could solve
its structure by X-ray crystallography (Figure 2C; Table 2; see
Supplemental Experimental Procedures for details).
The folds of the PrgK D1 and D2 domains are similar to those
of the equivalent domains in the EPEC T3SS ortholog EscJ (Fig-
ure S2), with backbone RMS deviations <1.5 A˚. Both D1 and D2
possess the canonical ring-building motifs observed in other
components of the T3SS basal body (Bergeron et al., 2013;
Spreter et al., 2009). We note that the first strand (termed b0
here for consistency) of EscJ D1 is not observed in PrgK,
possibly due to a single residue insertion at position 23 based
on the sequence alignment (Figure S1A), which either destabi-
lizes or prevents its formation. In addition, PrgK D2 possessesStructure 23, 161–172, January 6, 201a six-residue insertion (from 136–141) in a
loop region between strands b3 and b4
relative to EscJ (Figures S1A and S2). This
insertion is only partially ordered in the
PrgK D2 crystal structure (Figures 2C and
S2; see Supplemental Experimental Proce-
dures for details).
Modeling of the PrgK 24-mer Ring
We next applied our NMR and crystallo-
graphic structures to an EM-guided sym-
metry modeling protocol (Bergeron et al.,
2013) to model the PrgK 24-mer ring olig-
omer. Starting from the monomeric struc-
tures of D1 and D2, we applied the proce-
dure to the two domains independently
(Figure S3; Supplemental ExperimentalProcedures for details), allowing us to obtain a refined model
for PrgK (Figure 3A). Notably, despite this independent starting
set, the final model is globally similar in intermolecular packing
to the intact EscJ ring model derived from the crystallographi-
cally determined superhelical structure (Figures S3C and S3D),
with both domains in each of these orthologs adopting similar
orientations. We further note that the diameter of the D2 ring is
larger in the PrgK model, in agreement with the dimension of
the region of density assigned to PrgK in the EM map. It has
been reported that the EPEC T3SS possesses a narrower basal
body compared with the Salmonella SPI-1 T3SS (Sekiya et al.,
2001), suggesting that the larger PrgK D2 ring may correspond
to structural differences between the two systems.
We then observed that in the Rosetta-based PrgK model, the
D1 and D2 domains are in close proximity, forming a number of
notable direct interactions, including between residues 70–75 at
the surface of helix a2 of D1, and residues 111–126 on a4 and
strand b3 of D2 (Figure 3B). This prompted us to investigate
whether the D1 and D2 domains of PrgK interact in vitro. Using
NMR spectroscopy, we monitored spectral perturbations in the
15N-labeled D1 domain upon titration with unlabeled D2. As
shown in Figure 3C, we could observe a number of amide
1H-15N with progressively perturbed chemical shifts, implicating
residues 70–74 of helix a2, and to a lesser extent, those in the
spatially adjacent helix a1 (residues 38–42). These are largely hy-
drophobic residues, which cluster on the surface of D1 formed5 ª2015 Elsevier Ltd All rights reserved 163
Table 1. NMR and Refinement Statistics for the PrgK D1
Structure
PrgK19–76
NMR Distance and Dihedral Constraints
Distance constraints
Total NOE 1,912
Intraresidue 147
Interresidue
Sequential (ji – jj = 1) 1,197
Medium range (ji – jj < 4) 296
Long range (ji – jj > 5) 272
Hydrogen bonds 20
Total dihedral angle restraints
f 50
c 51
Structure Statistics
Violations (means ± SD)
Distance constraint violation (A˚) 0.013 ± 0.0003
Dihedral angle violation () 0.716 ± 0.0197
Deviations from idealized geometry
Bond lengths (A˚) 0.004
Bond angles () 0.6
Impropers () 0
Average pairwise root-mean-square
deviationa (A˚)
Heavy 1.15 ± 0.11
Backbone 0.63 ± 0.09
aPairwise root-mean-square deviation was calculated among 20 refined
structures.
Table 2. Data Collection and Refinement Statistics for the PrgK
D2- and D1-linker Structures
PrgK96–200 PrgK19–92
Data Collection
Space group C2 P21212
Cell dimensions
a, b, c (A˚) 77.19 34.74 64.03 88.12 112.10 112.10
a, b, g () 90.00 110.76 90.00 90.00 90.00 90.00
Resolution (A˚) 2.60 (2.7–2.6) 3.20 (3.37–3.20)
Rsym 0.071 (0.420) 0.165 (0.387)
I/sI 9.6 (2.1) 4.2 (2.1)
Completeness (%) 99.3 (94.2) 100.0 (100.0)
Redundancy 3.7 (3.6) 7.4 (7.5)
Refinement
Resolution (A˚) 2.6 3.2
Number of reflections 4992 17949
Rwork/Rfree 0.227/0.259 0.2468/0.2764
Number of atoms 1,344 6,912
Protein 1,337 6,912
Ligand/ion 0 0
Water 7 0
B factors (A˚2)
Protein 48.7 43.00
Water 45.2 N/A
Root-mean-square
deviation
Bond lengths (A˚) 0.009 0.011
Bond angles () 1.09 1.85
Values in parentheses are for highest resolution shell.
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Structural and Functional Characterization of PrgKby the two helices of the domain (Figure 3D) and match with the
interface generated in the PrgK 24-mermodel (Figure 3B). In par-
allel, a weak endothermic reaction was observed when we used
isothermal titration calorimetry (ITC) to monitor the titration of D1
against D2 (Figure 3E). However, over the available concentra-
tion range, we were unable to saturate the ITC- and NMR-moni-
tored titration, indicating that it is a weak interaction with an
affinity likely in the millimolar range (Figure 3C). Nevertheless,
this interaction is specific, as evidenced by its abrogation
when Tyr70 (a residue in helix a2 that is perturbed in the NMR
titrations; Figure 3C) is mutated to Ala (Figure 3E). Collectively,
these experiments both confirm that the isolated D1 and D2 do-
mains do interact and identify the D1 a1-a2 surface as the pri-
mary constituent of the D1-D2 interface (Figure 3D). Importantly,
this matches the interface generated in the PrgK 24-mer model
(Figure 3B). We emphasize that that the weak intermolecular
interaction of the isolated D1 and D2 is not unexpected given
that the two are removed from their native intramolecular
arrangement. In addition, cooperativity within the 24-mer may
‘‘amplify’’ the interaction.
The Linker Region of PrgK Promotes Oligomerization
We further noted that the residues involved in the D1-D2 interac-
tion identified in PrgK (Figure 3) are also present in the EscJ
superhelix crystal structure (Figure 4A). However, in the latter,164 Structure 23, 161–172, January 6, 2015 ª2015 Elsevier Ltd All rigwe observed that this interaction occurs between adjacent mol-
ecules, with D1 of molecule i interacting with D2 of molecule i+1
along the 24-mer oligomeric ring (we refer to this arrangement as
a ‘‘domain-swapped’’ conformation). This is likely driven by the
linker region, which is well ordered and forms a number of inter-
actions with D2 (Figure 4B), but not with D1 or with linker regions
from adjacent molecules. As we have modeled the two domains
D1 and D2 of PrgK independently, we cannot directly distinguish
whether the analogous D1-D2 interaction occurs in an inter-
molecular domain-swapped conformation (Figure 4C, right), as
opposed to an intramolecular interaction between domains
within a single chain (Figure 4C, left).
To answer this question, we engineered a construct of PrgK
D2 containing the upstream linker region (PrgK82–200). Unexpect-
edly, we observed that this protein forms a large homo-oligo-
meric complex, as shown using size-exclusion chromatography
with multiangle light scattering (SEC-MALS) (Figure 5A, brown
curve), whereas in the absence of the linker, D2 is monomeric
(purple curve). Importantly, the fold of D2 is likely globally
conserved in the PrgK82–200 construct, as shown by CD spec-
troscopy (Figure S4A), supporting that this oligomer is not consti-
tuted of unstructured, aggregated protein. A closer analysis of
the EscJ superhelix structure revealed that a conserved Phe at
position 89 in the linker region docks into a hydrophobic pocket
formed by two adjacent D2 subunits (Figure 5B). We thereforehts reserved
Figure 3. Modeling of the PrgK Ring
(A) Ribbon representation of the PrgK D1 and PrgK
D2 ring models in the relative orientation that
they adopt in the EM map density of the needle
complex used for modeling (see Supplemental
Experimental Procedures for details).
(B) Expanded view of adjacent D1 and D2 mole-
cules in the ring model. Residues of D1 that form
hydrophobic interactions with D2 are shown in
sticks.
(C) Section of the overlaid 15N-HSQC spectra of
PrgK D1 alone (red) and with increasing amount of
unlabeled D2 (up to 2:1 ratio for D2:D1, in the blue
spectrum). The residues experiencing a significant
chemical shift perturbation are indicated.
(D) These residues are shown in sticks on the D1
structure and clearlymatchwith residues that form
contacts with D2 in (B).
(E) ITC isotherms for the titration of PrgK D1
against PrgK D2. A weak (mM range) endothermic
interaction is observed between D1 and D2 (left),
which is disrupted when the Y70A mutation is
introduced to D1 (right).
See also Figure S3.
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Structural and Functional Characterization of PrgKhypothesized that this residue may also stabilize the PrgK82–200
oligomer. Indeed, we observed that a mutation of Phe89 to Ala
abrogates the oligomerization of PrgK82–200 (Figure 5A, green
curve) in vitro, confirming that the linker promotes D2 oligomer-
ization in a similar fashion to that observed in the EscJ superhelix
structure.We note that thismutation does not compromise T3SS
secretion in vivo, nor does the Y70Amutation (which disrupts the
oligomeric interaction between D1 and D2, see above). How-
ever, the double-mutant F89A/Y70A does abrogate secretion
(Figure S4C), which suggests that PrgK oligomerization is likely
stabilized by a number of interactions, including those involving
residues Phe89 and Tyr70. The NMR spectrum of PrgK19–200
with the Y70A/F89A mutations (Figure S4D) confirmed that the
overall fold of the protein is conserved, and its stability was
confirmed by differential fluorescence calorimetry (Figure S4B).
Further structural characterization of this protein was not
possible due to its propensity to undergo degradation (see
above).Structure 23, 161–172, January 6, 2015Finally, we used negative-stain EM to
analyze the PrgK82–200 oligomer and
observed that it forms ring-shaped/
tubular structures, with a conserved
diameter of 15–20 nm (Figure 5C). This
diameter is similar to that observed in
both the EscJ superhelix structure (Yip
et al., 2005) and in the density attributed
to the PrgK ring in the high-resolution
cryo-EM map of the basal body (Schraidt
and Marlovits, 2011). However, the struc-
tures vary in length from a few nm to over
100 nm (Figure 5C). Based on these ob-
servations, we propose that these fila-
ments consist of a superhelical assembly
of PrgK D2, which putatively forms in the
absence of the membrane-embeddedN-terminal lipidation that would restrict its assembly to a 2D
plane. We note that the heterogeneous nature of these struc-
tures prevented any high-resolution characterization, as would
be required to formally demonstrate their biological significance.
From these results, we conclude that in the EPEC EscJ and
Salmonella PrgK inner-membrane rings D1 and D2 likely form a
domain-swapped interface between adjacentmolecules.We hy-
pothesize that this allows for a more extensive set of interactions
within the 24-mer rings, including with the linker region, to pro-
mote oligomerization.
Interaction between D1 and Linker Prevents
Oligomerization
We have demonstrated that the linker is sufficient to promote
oligomerization of D2 in vitro, in the absence of D1. However,
no oligomerization was observed for the PrgK19–200 construct,
which includes D1, D2, and the linker (Figure 5A, blue curve).
This suggested the possibility that D1 may prevent spontaneousª2015 Elsevier Ltd All rights reserved 165
Figure 4. D1 and D2 Form an Intermolecular Interaction in the
Assembled 24 Mer
(A) Ribbon representation of an asymmetric unit from the EscJ crystal structure
containing four adjacent molecules in the superhelix (PDB ID: 1YJ7). Chains
are colored in yellow (chain i-1), cyan (chain i), green (i+1), and magenta (i+2).
(B) Ribbon and surface representation of one monomer from the EscJ
superhelix crystal structure, with the linker region shown in red. It is largely
ordered, with only four residues not resolved in the electron-density map.
Residues 86–89 form a short helix, which interacts with D2.
(C) Ribbon representation of successive molecules in our PrgK D1 and D2
model, colored as in (A). Two possible chain assignments can be made: in-
teracting D1 and D2 domains can belong to the same chain and form intra-
molecular interaction identified with red arrows (left) or belong to adjacent
chains and form a domain-swapped interaction (right). EscJ exhibits the latter,
whereas in our PrgK model these two conformations are indistinguishable, as
the linker (shown here with a dashed line) was not modeled.
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Structural and Functional Characterization of PrgKand potentially premature oligomerization of PrgK in the inner
membrane.
To validate this hypothesis, we engineered a protein construct
including D1 followed by the linker region (PrgK19–92). Using ITC,
we observed that the D1-D2 interaction is abrogated in the
context of the D1-linker construct (Figure 6A). To understand
how the presence of the linker residues abrogates this interac-
tion, we used NMR spectroscopy to characterize PrgK19–92
further. Unexpectedly, we observed that many residues yield
two distinct sets of NMR signals (Figure 6B), indicative of two
conformations in slow exchange, referred to as ‘‘population A’’
and ‘‘population B,’’ with the peaks yielded by population A
consistently more intense than those yielded by population B.
We mapped chemical shift differences between these two pop-
ulations along the sequence, which inferred that structural differ-
ences occur primarily in the a helices and the following linker
(Figure 6C). However, the chemical shift-derived secondary
structure prediction suggests that population A and population166 Structure 23, 161–172, January 6, 2015 ª2015 Elsevier Ltd All rigB possess similar secondary structure elements. The Random
Coil Index (Berjanskii and Wishart, 2007) also reveals that resi-
dues 70–82 (end of helix 2 and beginning of the linker) are less
flexible in population A than in population B (Figure 6C). We
note that most peaks found in the spectrum of PrgK D1 overlay
onto the peaks assigned to population B of PrgK19–92 (Fig-
ure S5A), indicating that in population B the linker does not
interact significantly with the D1 domain. These results suggest
that in population A, residues 76–82 of the linker interact with
D1, while this interaction is not present in population B. Impor-
tantly, the spectrum of PrgK19–92 overlay well onto that of the
construct that included both PrgK domains (PrgK19–200; Fig-
ure S5B), with the two peaks formed by population A and popu-
lation B clearly observable in the larger construct. This demon-
strates that the interaction between D1 and the linker is also
present in the purified, monomeric full-length protein (lacking
the N-terminal lipidation site and C-terminal TM region), which
could not be characterized further due to its instability (see
above).
Next, we were able to solve the crystal structure of PrgK19–92
(Figure 6D; Table 2; see Supplemental Experimental Procedures
for details). In this structure, part of the linker (residues 75–82) is
well ordered and clearly located in the D2-binding groove of D1,
in agreement with the NMR results described above. Notably Tyr
75, Leu 77, and Pro 78 form hydrophobic interactions with loop
1, helix a1, and helix a2 of D1 (Figure 6E). We note that only the
linker-bound conformation, corresponding to population A, was
found in the crystal. It is also noteworthy that this protein forms a
superhelical arrangement in the crystal lattice, in which intermo-
lecular contacts supports the D1 ringmodel reported above (Fig-
ures S5C and S5D). Together, these results demonstrate that D1
interacts with the linker, through the groove formed in between
the two helices of the domain. This corresponds to the surface
of D1 that interacts with D2, as shown by our modeling and
NMR results (see Figures 6C and 3D). From this observation,
we conclude that the linker interacts with the D2 binding pocket
of D1, thereby sterically blocking the D1-D2 interaction. Further-
more, by sequestering the linker, D1 likely also prevents sponta-
neous oligomerization of PrgK.
To provide additional support for this hypothesis, we used
NMR spectroscopy to monitor the titration of PrgK D1 with an
isolated polypeptide corresponding to the linker sequence
(PrgK76–97) fused to SUMO. As summarized in Figure S5E, a
number of D1 residues showed amide chemical shift changes
upon peptide addition. These residues clustered around the he-
lical regions of D1 (Figure S5G). This confirms that the linker
binds the same region of D1, whether present as a separate
peptide or in the intramolecular context of PrgK19–92. Further-
more, chemical shift analysis (Figure S5F) allowed us to obtain
a Kd value of 100 mM (±40 mM) for the intermolecular D1-linker
interaction. This is at least an order of magnitude tighter than
the intermolecular D1-D2 interaction. The preferential D1-linker
interaction is consistent with the observations by NMR and
SEC-MALS that PrgK19–200 is monomeric.
Structural Basis for the PrgH-PrgK Interaction
We next combined the 24-mer models of PrgK D1 and D2
described above (Figure 3A), with the PrgH oligomeric model re-
ported previously (Bergeron et al., 2013), and applied the ringhts reserved
Figure 5. The Linker Promotes PrgK D2
Oligomerization
(A) SEC-MALS analysis of the PrgK D2 constructs,
with the elution volume from a Superdex 200 col-
umn on the x axis, and the calculated molecular
mass along the y axis. PrgK82–200 forms a large
oligomeric structure (brown) withmolecular weight
varying from 1.5 to 10 MDa, whereas PrgK96–200 is
monomeric, with a measured molecular mass of
10.5 kDa (purple). Oligomerization of PrgK82–200 is
abrogated by the F89A mutation, which is mono-
meric with a measured molecular weight of
15.2 kDa (green). Finally, the full-length protein,
containing D1, the linker and D2, is strictly mono-
meric, with a measured molecular weight of
22.6 kDa (blue), suggesting that D1 abrogates the
linker-induced oligomerization of D2.
(B) Domain D2 of two adjacent molecules in the
EscJ crystal structure (PDB ID: 1YJ7) (Yip et al.,
2005) are shown in ribbon and surface represen-
tation, with the linker region of molecule i shown in
ribbon. The position of Phe 89, which promotes
oligomerization in PrgK82–200, is shown with a blue
arrow.
(C) Negative-stain EM analysis of purified PrgK82–
200 protein, showing large tubular assemblies of
constant diameter but varying lengths. Individual
ring structures, with dimensions that are consis-
tent with EscJ 24-mers, are shown at closer
magnification on the top right.
See also Figure S4.
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Structural and Functional Characterization of PrgKmodeling procedure on the collective set (see Figures S6A and
S6B; Supplemental Experimental Procedures for details). From
this we obtained amodel for the PrgH-PrgK 48-mer ring complex
(Figure 7A), which agreeswith the EMmap (Figure S6C), and pre-
viously published biochemical data (Table S1). We emphasize
that the model includes a number of assumptions, such that
the subunits are related by strict symmetry, and that the struc-
tures of individual domains are not significantly modified in the
assembled complex. Higher resolution EM maps, crystal struc-
tures of oligomerized domains, and additional mass spectrom-
etry/crosslinking and mutagenesis interaction data should allow
for generation of models with greater accuracy in the future. In
particular, while the agreement with the NMR titration and
EscJ crystallographic contacts supports the PrgK model, addi-
tional experimental restraints would be necessary to better
define the PrgH-PrgK interaction.
In thismodel, we observe that there are predicted contacts be-
tween the periplasmic domains of PrgH and PrgK monomers
(Figure 7B). However, this intermolecular interface is relatively
limited (collectively 1,440 A˚3 of buried surface for the modeled
complex) and with the major interactions occurring between
the C-terminal region of PrgH and PrgK D2. This is in agreement
with the highest resolution (10 A˚) EMmap (Schraidt and Marlo-
vits, 2011), in which a large cavity is observed between the
sections of the density attributed to PrgH and PrgK (Figure 7B).
Specifically, in the PrgH-PrgK model, the conserved Asp 333
(located on helix 2 in the third ring-building motif domain of
PrgH) is buried in a well-ordered, positively charged pocketStructure 23, 16formed by helix a4 of two adjacent PrgK D2 subunits (Figure 7C).
Consistent with this arrangement, we were not able to detect an
interaction between the periplasmic domain of PrgH and PrgK
in vitro (data not shown), likely because this construct does not
form the PrgH binding pocket in its monomeric state. The highly
oligomeric and heterogeneous state of the PrgK82–200 construct
did not allow for further investigation of its interaction with PrgH.
As shown in Figure 7D, mutation of Asp 333 to Arg in PrgH abro-
gates secretion (without affecting the structure of the isolated
domain; Figures S6D and S6E), supporting the essential role of
this residue. In PrgK, mutation of the conserved Lys 168 to Glu
does not alter secretion, but it is abrogated when both Lys 168
and Arg 169 are mutated to Ala. CD spectroscopy and differen-
tial scanning calorimetry (DSF) suggest that PrgK D2 is largely
folded in the presence of these mutations (Figures S6F and
S6G). We also observe that the loop located between strand
b5 and helix a5 of D2, which is poorly ordered in the PrgK crystal
structure (see Supplemental Experimental Procedures), is
located in the cavity described above (Figure 7B) in our PrgK
ring model. Neither this loop nor the extended loop between
strands b4 and b5 is accounted for by EM map density. It is
therefore possible that flexible regions of PrgK could potentially
form additional contacts with PrgH upon complex formation.
DISCUSSION
In this study, we characterize structural and functional features
of the modular ring building domains of the inner-membrane1–172, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 167
Figure 6. D1 Sequesters the Linker to Prevent Oligomerization
(A) ITC isotherms for the titration of PrgK D1 against D2. A schematic representation of the experiments performed is shown on the right. In the presence of the
linker region fused to D1 (PrgK19–92), the two domains do not interact. The top is a repeat of the experiment shown on Figure 3E (left).
(B) Assigned 15N-HSQC spectrum of PrgK19–92 (insert for the crowded region). Black lines connect peaks arising from the same residue in the two populations (A
and B) of this protein. The asterisk indicates peaks assigned to the two cloning remnant residues at the N terminus of the PrgK sequence.
(C) The weighted combined amide 15N and 1HN chemical shift differences (D(H,N)) between corresponding peaks for population A and population B is plotted
along the protein sequence (top). The perturbed amides cluster in helices a1, a2 and the linker region. Secondary structures for the populations A and B of
PrgK19–92, obtained from their assigned
1HN, 15N, 13Ca, and 13Cb chemical shifts using the program SSP (Marsh et al., 2006), is shown in the middle. Scores of +1,
0, and1 correspond to helices, random coils, and strands, respectively. The RandomCoil Index profiles for the populations A and B of PrgK19–92, obtained from
their assigned 1HN, 15N, 13Ca, and 13Cb chemical shifts using the RCI server (Berjanskii and Wishart, 2007), are shown at the bottom. Residues 72–84 are less
disordered in population A than in population B.
(D) Crystal structure of PrgK19–92, in ribbon representation, with corresponding sequence numbering shown. Secondary structure elements are labeled as in
Figure S1A, and blue to red rainbow coloring indicates N- to C-terminal directionality (see Table 2 for statistics).
(E) Close-up view of the linker region (in red) interaction with D1 (green). The composite 2Fo-Fc omit map (0.05% atoms omitted, generated by Phenix) is shown,
contoured at 1 s around residues 75–82. Residues that form hydrophobic interactions between D1 and the linker are shown as sticks.
See also Figure S5.
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Structural and Functional Characterization of PrgKprotein PrgK, from the prototypical Salmonella SPI-1 T3SS
injectisome. We demonstrate that its C-terminal TM helix is
not essential for injectisome assembly/effector secretion
and report the crystallographic and NMR structures of its
two globular domains in isolation. Using our previously devel-
oped molecular modeling method combining atomic struc-
tures of individual domains, EM maps, and symmetry, we
have obtained a model of the PrgK periplasmic ring. Further
analysis in the context of its binding partner PrgH provides a
starting point for understanding the intimate molecular inter-
action between these two ring-forming proteins. Finally, we
propose that the linker region between the two globular ring-
building domains of PrgK may play a regulatory role in oligo-
merization, by promoting an intermolecular, domain-swapped168 Structure 23, 161–172, January 6, 2015 ª2015 Elsevier Ltd All rigdisposition of D1 and D2 that stabilizes the 24-mer ring
complex.
Previous studies have shown that coexpression of PrgK and
PrgH leads to the spontaneous formation of the inner-membrane
ring structures. In contrast, expression of PrgK or PrgH alone
forms oligomers, but lacks the ring-like conformation observed
in the fully assembled injectisome (Kimbrough and Miller,
2000). In this light, the data reported here suggest a molecular
mechanism for the assembly of the PrgH-PrgK rings. We pro-
pose that PrgK can adopt two conformations: an assembly-
incompetent conformation with D1 sequestering the linker and
an assembly-competent conformation where the linker pro-
motes oligomerization. This conformation is likely stabilized by
the insertion of a PrgH molecule in between two adjacent PrgKhts reserved
Figure 7. Structural Model of the PrgH-
PrgK Complex
(A) Ribbon representation of the lowest energy
model for the PrgH-PrgK 48-mer model, in the EM
density of the map used for the Rosetta modeling
(EM Data Bank ID: 1875). Adjacent subunits of
PrgH are colored pink and orange, and adjacent
subunits of PrgK are in green and yellow.
(B) Side view of a single PrgH, PrgK D1 and PrgK
D2 subunit, in orange and green, respectively, with
the EM density in gray (contour level = 0.24). The
location of the proposed PrgH-PrgK interaction,
as well as the large cavity between the two mole-
cules, is indicated.
(C) Close-up view of the PrgH-PrgK interface.
Adjacent PrgK D2 molecules are in green and
yellow, respectively, while the PrgH molecule is in
orange. The residues that participate in the PrgH-
PrgK interaction are indicated; a negative-charged
residue on PrgH, Asp 333, docks in a positively
charged pocket formed by His 162 and Lys 168
from one PrgK subunit (i) and Arg 169 and His 162
from the adjacent PrgK subunit (i+1). A surface
representation of the PrgK dimer, colored ac-
cording to the surface charge calculated using
APBS (Baker et al., 2001), is shown.
(D) SDS-PAGE gel of proteins secreted by
S. typhimurium strains containing mutations of
PrgH or PrgK. FliC is used as a loading control. The
western blots for PrgH (left) or PrgK (right) from
isolated membrane fractions of the corresponding
samples are shown below. In PrgH, mutation of
Asp 333 abrogates secretion, while in PrgK mu-
tation of Lys 168 to Glu has no phenotype, but
secretion is abrogated when both Lys 168 and Arg
169 are mutated to Ala. These results support the
essential role of the proposed PrgH-PrgK interface
in T3SS assembly. We note that protein levels are
decreased for all mutants compared with WT,
likely caused by increased protein turnover in the
absence of complex formation (Schraidt and
Marlovits, 2011).
See also Figure S6 and Table S1.
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Structural and Functional Characterization of PrgKmolecules, which would explain why PrgK or PrgH alone do
not spontaneously form ring-like oligomers. Propagation of this
ring-initiation step leads to the formation of a stable PrgH-PrgK
24-mer ring pair (Figure 8). We argue that such a coordinated
oligomerization of these two conserved luer lock rings would
be essential to allow their formation only upon encompassing
the several inner-membrane spanning export apparatus proteins
that they are presumed to contain (Wagner et al., 2010).
We acknowledge that this proposed mechanism is derived
largely from the biochemical and structural behavior of a soluble,
monomeric fragment of PrgK and may therefore not reflect the
behavior of the full-length membrane-embedded protein in vivo.
However, the correlation between the impact of PrgK mutations
in vitro and in vivo, as well as the ability to isolate a PrgH/K com-
plex (Kimbrough and Miller, 2000), supports the validity of the
proposed model. Although perhaps intuitively sensible that a
large complex such as the PrgK-PrgH oligomer would assemble
in a coordinated, step-wise manner, additional experimentalStructure 23, 16validation, such as the isolation and molecular characterization
of assembly intermediates, will be required to confirm the model
proposed in Figure 8.
A second aspect of this study is the proposed model for
the PrgH-PrgK interaction from our Rosetta-based analysis.
Perhaps surprising is the somewhat limited nature of this
interface that, although bolstered by stoichiometry, suggests
additional functionalities, such as the lipidated and/or mem-
brane-spanning regions of PrgH and PrgK, may also play a
role. Alternatively, the presence of peptidoglycan, cytoskeleton,
or other structural components in the periplasm may also act in
stabilizing the complex in the membrane environment. Further,
both the EM map density and our symmetry modeling suggest
the presence of a large cavity between PrgH and PrgK (Figure 7),
with few interactions occurring in the periplasmic region
(although it is possible that in situ this cavity is occupied by other
components of the injectisome that perhaps are lost during nee-
dle complex purification in the EM analysis). This cavity could1–172, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 169
Figure 8. Molecular Model for the Assembly of the PrgH-PrgK Ring
(A) We propose that initially PrgK exists in a monomeric state, while localized in the inner membrane via nature of the N-terminal lipidation site and the C-terminal
TM helix. D1 interacts with the linker, preventing oligomerization. The C-terminal TM helix, which is not essential for assembly (as shown in Figure 1C) is omitted
for clarity.
(B) The linker then dissociates from D1, exposing the Tyr 70-containing hydrophobic pocket, as well as Phe 89.
(C) PrgK then recruits adjacentmolecules via a range of intermolecular interactions involving both domains and the linker region, indicated by dotted black circles.
(D) PrgH molecules insert in the pocket formed by two adjacent PrgK molecules, forming a heterotrimeric intermediate.
(E) PrgH-PrgK heterotrimers further oligomerize to obtain an assembled PrgH-PrgK complex.
Structure
Structural and Functional Characterization of PrgKallow for a degree of structural plasticity in the basal body, as
observed recently in situ for the Yersinia T3SS (Kudryashev
et al., 2013). The presence of a cavity into which solvent can
diffuse between PrgH and PrgK could also have favorable impli-
cations in the design of T3SS assembly inhibitors.
In conclusion, in this study, we have obtained the structures of
isolated domains of PrgK and used interaction studies and
computational methods to propose a structural model for the
PrgH-PrgK 48-mer periplasmic rings. This provides insights
into the interaction between PrgH and PrgK. We also report
biochemical, structural, and functional data suggesting a step-
wise assembly for the PrgH-PrgK complex, promoted by struc-
tural rearrangement in PrgK. While integrative structural biology
approaches enable the piecing together of the architecture of
large macromolecular assemblies, the addition of a temporal
dimension, including assembly, disassembly, and/or functional
changes, such as that probed here, is an important further
element toward understanding and targeting complex nanoma-
chines such as the T3SS at the molecular level.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
All constructs were cloned in a pET28a plasmid (Novagen), with an N-terminal
His10-tag fusion followed by a thrombin cleavage site. Plasmids were trans-
formed into E. coli BL21(DE3) cells, and transformants were grown to log
phase at 37C. Expression was induced with 1 mM isopropyl b-D-1-thiogalac-
topyranoside at 20C for 16 hr. Harvested cells were resuspended in lysis
buffer (50 mMHEPES [pH 8.0], 150mMNaCl) with protease inhibitors (Roche).
Cells were lysed by sonication. Clarified lysate was run through Zn-chelating
sepharose, and the proteins were eluted with 500 mM imidazole. The His-
tag was cleaved with Thrombin (Roche), and proteins were further purified
by gel filtration with a Superdex 75 column (GE Healthcare).
For NMRexperiments, 15N- and 15N, 13C-labeled proteins were expressed in
E. coli BL21(DE3) in M9 minimal media supplemented with 1 g/l 15NH4Cl and
2.5 g/l 13C-labeled glucose. The proteins were purified as above.
NMRSpectra Acquisition, Assignment, and Structure Determination
For all NMR experiments, protein samples were dialyzed into 50 mM HEPES
(pH 6.8), 10% D2O, and concentrated to 0.5–1 mM. Standard 2D and 3D
spectra for backbone and side-chain assignments were collected using170 Structure 23, 161–172, January 6, 2015 ª2015 Elsevier Ltd All rigeither a 600 or 850 MHz Brucker Avance III spectrometer, equipped with
TCI cryoprobe. All spectra were processed using NMRPipe (Delaglio et al.,
1995) and analyzed with SPARKY (T.D. Goddard and D.G. Kneller, University
of California, San Francisco) (see Supplemental Experimental Procedures for
details).
Crystallization and X-Ray Crystallographic Structure Determination
Crystals of PrgK98–200 and PrgK19–92 were obtained in 100mM sodium acetate
(pH 5.5), 20%polyethylene glycol (PEG) 6000, 50mMNaCl, 50mMMgCl2, and
80 mM phosphate buffer (pH 4.0), 20 mM Tris pH 7.0, 25% PEG 300, 20 mM
MgCl2, 20 mM NaCl, respectively, by vapor diffusion, using the sitting drop
method. X-ray diffraction data were collected at the Canadian Light Source
beamline 08B1-1. Phases were obtained by molecular replacement with the
program Phaser (McCoy et al., 2007). The PrgK98–200 structure was refined
to 2.65 A˚ resolution and the PrgK19–92 to 3.2 A˚ resolution (Table 2; see Supple-
mental Experimental Procedures for details).
EM-Guided Symmetrical Modeling
Ring modeling for PrgK D1 and PrgK D2 was performed as described previ-
ously (Bergeron et al., 2013; see Supplemental Experimental Procedures for
details).
For the PrgK D1-D2-PrgH model, individual lowest energy ring models of
PrgK D1, PrgK D2, and PrgH were combined into a single coordinate file
and used to generate the input for the phase II all atom refinement procedure
(see Supplemental Experimental Procedures for details).
In Vivo Assays
Salmonella typhimurium LT2 strains containing a deletion of the prgH or prgK
genewere complementedwith plasmids containing the corresponding gene or
mutants, all with a C-terminal 6xHis tag, which does not affect T3SS function
(Schraidt et al., 2010), and effector protein secretion was monitored as
described previously (Kimbrough and Miller, 2000). Needle complexes were
purified as described previously (Bergeron et al., 2013; Kubori et al., 1998;
Schraidt et al., 2010).
Electron Microscopy
Samples of PrgK82–200 were diluted to 1 mg/ml in 50 mM HEPES (pH 7.0),
150 mM NaCl. Samples of purified needle complex particles were diluted
to 0.2 mg/ml in 10 mM Tris (pH 8.0), 500 mM NaCl, 5 mM EDTA, and
10 mM lauryldimethylamine oxide. All samples were applied on glow-dis-
charged carbon grids and stained using 0.75% uranyl formate. Images
were collected on a Technai G2 transmission electron microscope (FEI) oper-
ating at 200 kV and equipped with a high-speed AMT 2K side-mount CCD
camera.hts reserved
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The atomic coordinates for the various structures have been deposited in the
PDB ID (2MKY, 4OYC, and 4W4M). The lowest all-atom energy PrgH-PrgK
Rosetta model has been deposited in the PDB (3J6D).
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